英科醫療(300677.SZ):子公司擬50億元投資英科醫療產業園年產520億隻(5200萬箱)高端醫用手套項目
格隆匯 3 月 1日丨英科醫療(300677.SZ)公佈,根據公司戰略發展需要,同時為緩解快速增長的一次性手套市場需求,鞏固公司在一次性醫療防護手套領域的行業地位,促進業務進一步增長,公司的全資子公司安徽英科醫療用品有限公司(“安徽英科”)擬投資50億元人民幣投資英科醫療產業園年產520億隻(5200萬箱)高端醫用手套項目。
公司全資子公司安徽英科投資建設英科醫療產業園年產520億隻(5200萬箱)高端醫用手套項目會進一步擴大公司產能、發揮規模效應、鞏固公司在行業內的領先地位,有利於進一步提升公司業績,增強核心競爭力,符合公司戰略發展方向。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.